COVID-19 Clinical Research Center | About the CCRC
Mark Sulkowski, MD; Director
Kim Kafka, BSN, RN; Program Manager; Research Nurse Manager, CRUs
Stephanie Swords, MA, CCRP; COVID Research Operations Administrator
Kelly Dooley, MD, MPH, PhD
David Hager, MD, PhD
William Nelson, MD, PhD, Chair
Andrea Cox, MD, PhD
Daniel Ford, MD, MPH
Elizabeth Jaffee, MD
Sumati Murli, PhD
Antony Rosen, MB, ChB, MS
Richard Rothman, MD, PhD
Lauren Sauer, MS
Megan Singleton, JD, MBE, CIP
Jeremy Sugarman, MA, MD, MPH
Mark Sulkowski, MD
David Thomas, MD, MPH
RATIONALE FOR COORDINATING COVID-19 CLINICAL RESEARCH
- Risks to patients, study participants, and staff during the pandemic.
- Patients with COVID-19 presenting to hospitals and facilities across the Johns Hopkins Health System are being cared for by newly formed clinical teams.
- Enhance research participation across the health system to inform the development of evidence-based means of treating COVID-19.
- Not overwhelm patients with multiple requests regarding research participation.
- The need to be sensitive to rapidly emerging data (interventions and the contours of the pandemic).
- The opportunity to learn from different expertise.
- Limits to the number of treatment trials we can support in terms of the number of patients with COVID-19 that meet inclusion/exclusion criteria and resources needed to open, maintain and successfully complete clinical trials.
- Our commitment that patients participate in research that is likely to yield interpretable results.
- Prioritize which protocols will receive university support, including review by the IRB.
- Prioritize supplies for non-essential resources such as PPE and reagent or specimen collection and transfer materials.
- Use resources efficiently.